Literature DB >> 7844669

Expanded spectrum of herpes simplex encephalitis in childhood.

Y Schlesinger1, R S Buller, J E Brunstrom, C J Moran, G A Storch.   

Abstract

We designed a polymerase chain reaction method to detect herpes simplex virus (HSV) DNA in spinal fluid from patients with encephalitis. The polymerase chain reaction amplified a 211 base-pair segment of the HSV DNA polymerase gene. Applying this method, we diagnosed HSV type 1 infection in three young children, aged 7 to 13 months, who had atypical forms of the illness. On the basis of magnetic resonance imaging, their disease was diffuse or multifocal in two cases and, in all three, lacked the temporal lobe involvement considered characteristic of HSV encephalitis beyond the neonatal period. Most of the diffuse or multifocal abnormalities detected by magnetic resonance imaging were not apparent by computed tomography. Restriction enzyme analysis of the polymerase chain reaction products from all three patients indicated that their disease was caused by HSV type 1. We conclude that in preschool-age children beyond the neonatal period, the spectrum of HSV encephalitis includes multifocal or diffuse involvement of the brain, which may be detected most efficiently by magnetic resonance imaging. The polymerase chain reaction method has the potential for providing an early diagnosis, but further studies are required to define the sensitivity and specificity of the polymerase chain reaction before it can be used for routine clinical decision making.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844669     DOI: 10.1016/s0022-3476(95)70550-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Confirmation of low-titer, herpes simplex virus-positive specimen results by the enzyme-linked virus-inducible system (ELVIS) using PCR and repeat testing.

Authors:  N Patel; L Kauffmann; G Baniewicz; M Forman; M Evans; D Scholl
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature.

Authors:  Nicholas A Morris; Tamara B Kaplan; Jenny Linnoila; Tracey Cho
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

4.  Acute childhood encephalitis and meningoencephalitis: Diagnosis and management.

Authors:  E L Ford-Jones; D Macgregor; S Richardson; F Jamieson; S Blaser; H Artsob
Journal:  Paediatr Child Health       Date:  1998-01       Impact factor: 2.253

5.  Herpes simplex encephalitis presenting with exclusively frontal lobe involvement.

Authors:  Sean W Taylor; Donald H Lee; Alan C Jackson
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

Review 6.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

Review 7.  Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity.

Authors:  Shen-Ying Zhang
Journal:  Hum Genet       Date:  2020-02-10       Impact factor: 4.132

8.  Herpes simplex serious neurological disease in young children: incidence and long-term outcome.

Authors:  Katherine N Ward; Anu Ohrling; Naomi J Bryant; Jennifer S Bowley; Euan M Ross; Christopher M Verity
Journal:  Arch Dis Child       Date:  2011-06-17       Impact factor: 3.791

Review 9.  Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.

Authors:  Paola Cinque; Simona Bossolasco; Ake Lundkvist
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.